Navigating the treatment of RRMM with BCMA-directed therapies: Updates from COMy, ASCO and EHA 2025

touchCONGRESS for touchHAEMATOLOGY and touchONCOLOGY Listen to multiple myeloma expert Prof. Philippe Moreau review key data for BCMA-targeting agents in the treatment of relapsed/refractory multiple myeloma presented at the international Controversies in Multiple Myeloma (COMy), American Society of Clinical Oncology (ASCO) and European Hematology Association (EHA) 2025 congresses. Prof. Moreau is then joined by fellow experts Dr Paola Neri and Prof. Hermann Einsele to discuss how these data may apply in clinical practice. Overview Data reviews with Prof. Moreau Expert panel discussions with Prof. Moreau, Dr Neri and Prof. Einsele on the themes below Clinical themes Approved BCMA-directed therapeutic approaches  Practical application of BCMA-directed therapies Future of treating RRMM: Emerging BCMA-directed therapies and combinations The internationally renowned multiple myeloma expert faculty Prof. Philippe Moreau: Nantes, France Prof. Hermann Einsele: Würzburg, Germany Dr Paola Neri: Calgary, AB, Canada This touchPODCAST is for HCPs outside of the USA.  This activity is funded by an independent medical education grant from GSK. This activity is provided by touchIME. touchIME is an EBAC® accredited provider. For further information, visit our website: www.touchHAEMATOLOGY.com and www.touchONCOLOGY.com

touchEXPERT FOCUS for touchDERMATOLOGY Listen to Prof. Ilona Frieden share expert insights on the clinical management of infantile haemangiomas, with a focus on timely referral and effective risk stratification. She also explores current and emerging treatment options and practical strategies to support families throughout a patient’s care journey.  The expert: Prof. Ilona Frieden, University of California, San Francisco, CA, USA This touchPODCAST is for HCPs outside of the UK only. This activity is funded by an independent medical education grant from Pierre Fabre Pharmaceuticals, Inc. This activity is jointly provided by USF Health and touchIME in collaboration with our education partner, Pediatric Dermatology Research Alliance (PeDRA). For further information visit our website: https://touchdermaime.org/

touchIN CONVERSATION for touchONCOLOGY Listen to two oncologists discuss the incorporation of antibody–drug conjugates (ADCs) into the treatment of metastatic breast cancer, tackling questions submitted by the oncology community. They discuss how treatment can be guided by biomarkers, give practical insights into creating a personalized care plan for patients, and share strategies for managing ADC-associated toxicities. The experts Prof. Giuseppe Curigliano, European Institute of Oncology and University of Milan, Italy Dr Alison Conlin, Providence Cancer Institute, Portland, OR, USA This touchPODCAST is for HCPs outside of the UK.  This activity is funded by an independent medical education grant from Gilead Sciences, Inc. The activity is jointly provided by USF Health and touchIME. touchIME is an EBAC® accredited provider. For further information, visit our website: https://touchoncologyime.org/adcs-in-the-treatment-of-mbc/  

touchEXPERT FOCUS for touchONCOLOGY Listen to a series of short interviews with three leading experts discussing the application of immunotherapy in triple-negative breast cancer (TNBC). The experts explore the latest data and guideline recommendations for immunotherapy in early-stage and metastatic TNBC, and how to maximize treatment benefits.  The experts: Prof. Sherko Kümmel – Kliniken Essen-Mitte, Essen, Germany Prof. Rebecca Dent – National Cancer Center Singapore, Singapore Prof. Peter Schmid – Barts Cancer Institute, London, UK This touchPODCAST is for healthcare professionals outside of the UK. This activity is funded by an independent medical education grant from Merck Sharp & Dohme LLC.  This activity is jointly provided by USF Health and touchIME. touchIME is an EBAC® accredited provider. For further information visit our website: https://touchoncologyime.org/management-of-tnbc-with-immunotherapy/  

touchEXPERT FOCUS for touchRESPIRATORY Listen to Prof. Jonathan Spicer share expert insights on immunotherapy in early-stage non-small cell lung cancer (NSCLC). He explores current treatment strategies, highlights the role of neoadjuvant, perioperative and adjuvant approaches, and considers practical aspects of clinical implementation. The expert Prof. Jonathan Spicer, McGill University, Montreal, Canada This touchPODCAST is for HCPs outside of the UK only. This activity is funded by an independent medical education grant from Merck Sharp & Dohme LLC. The activity is jointly provided by USF Health and touchIME. touchIME is an EBAC® accredited provider. For further information, visit our website: https://touchrespiratoryime.org/touchexpert-focus-immunotherapy-early-stage-nsclc/  

touchEXPERT FOCUS for touchONCOLOGY Listen to Prof. Jonathan Spicer share expert insights on immunotherapy in early-stage non-small cell lung cancer (NSCLC). He explores current treatment strategies, highlights the role of neoadjuvant, perioperative and adjuvant approaches, and considers practical aspects of clinical implementation. The expert Prof. Jonathan Spicer, McGill University, Montreal, Canada This touchPODCAST is for HCPs outside of the UK only. This activity is funded by an independent medical education grant from Merck Sharp & Dohme LLC. The activity is jointly provided by USF Health and touchIME. touchIME is an EBAC® accredited provider. For further information, visit our website: https://touchoncologyime.org/touchexpert-focus-immunotherapy-early-stage-nsclc/  

NEW touchCASES for touchINFECTIOUS DISEASES Listen to  Prof. José Arribas, a leading HIV expert, and Ms Harriet Langanke, a journalist and HIV activist, discuss personalized care strategies for people living with HIV, focusing on three key concerns: weight gain, pill fatigue and treatment initiation. The experts: Prof. José Arribas, University Hospital La Paz, Madrid, Spain, Ms Harriet Langanke, GSSG, Cologne, Germany This touchPODCAST is for HCPs outside of the UK This activity is funded by an independent medical education grant from Viiv Healthcare. This activity is jointly provided by USF Health and touchIME. touchIME is an EBAC® accredited provider. For further information, visit our website: https://touchinfectiousdiseases.com

touchIN CONVERSATION for touchNEUROLOGY Listen as two experts discuss the practical considerations for the diagnosis of myasthenia gravis (MG), serological subgroup testing and the implementation of newly available treatments for MG. They will also consider the emerging treatments for generalized MG and the potential impact on the therapeutic landscape. The experts Dr Carolina Barnett-Tapia, University of Toronto, Toronto, ON, Canada Prof. Nils Erik Gilhus, University of Bergen and Haukeland University Hospital, Bergen, Norway This touchPODCAST is for HCPs outside of the UK. This activity is funded by an independent medical education grant from Healthcare Business of Merck KGaA, Darmstadt, Germany.  This activity is jointly provided by USF Health and touchIME.  touchIME is an EBAC® accredited provider. For further information visit our website: www.touchneurology.com

touchFOCUS for touchONCOLOGY In this concise interview, Dr Christine Bestvina discusses the key clinical questions surrounding currently approved RET inhibitors in NSCLC. The expert: Dr Christine Bestvina - University of Chicago, Chicago, IL, USA This touchPODCAST is for HCPs outside the UK.  This activity is funded by an independent medical education grant from Rigel Pharmaceuticals Inc. This activity is jointly provided by USF Health and touchIME. For further information visit our website: touchoncology.com

touchFOCUS for touchRESPIRATORY In this concise interview, Dr Christine Bestvina discusses the key clinical questions surrounding currently approved RET inhibitors in NSCLC. The expert: Dr Christine Bestvina - University of Chicago, Chicago, IL, USA This touchPODCAST is for HCPs outside the UK.  This activity is funded by an independent medical education grant from Rigel Pharmaceuticals Inc. This activity is jointly provided by USF Health and touchIME. For further information visit our website: touchrespiratory.com